In the following interview by Laborjournal, a German Life Science journal, our CEO Lukas Langenegger talks about our innovative approach to fight sepsis and points out the great advantage over blood purification by traditional dialysis. Learn more about the working principle of our magnetic nanoparticles and how we strive for the highly specific removal of disease causing agents from a patient's blood stream. Link to article Laborjournal

Please vote for hemotune! Since 2011, the Top 100 Swiss Startup Award by Venturelab showcases the 100 most-innovative and promising Swiss startups. Seize this unique opportunity and support hemotune! Our team composed of young and enthusiastic scientists, engineers, clinicians, innovators and entrepreneurs works jointly on a revolutionary medical device to fight sepsis. To register your voice, either click on the image above this text or open the link below. https://www.startup.ch/index.cfm?page=129367&profil_id=11726 Thank you for your support!